Effects of eradication on proteinuria: a prospective study

Basit Öğe Kaydı
dc.contributor.authorAydogan, Timucin
dc.contributor.authorUlas, Turgay
dc.contributor.authorSelcoki, Yusuf
dc.contributor.authorAlkan, Rabia
dc.contributor.authorYilmaz, Omer Caglar
dc.contributor.authorYalcin, Kadir Serkan
dc.contributor.authorInan, Osman
dc.date.accessioned2024-04-24T16:01:55Z
dc.date.available2024-04-24T16:01:55Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground Helicobacter pylori ( H. pylori) is one of the most common bacterial infections, seen in humans worldwide and its possible relationship to different diseases is a focus of attention nowadays. The aim of this study was to analyse the effects of eradication on proteinuria. Ninety-nine patients suffering from dyspeptic complaints were recruited in this prospective study. The patients were divided into two groups according to the presence of infection. Thus, a total of 67 positive and 32 negative patients were studied. The positive patients' group was divided into two groups according to response to eradication treatment. A total of three groups were formed, viz; group 1 comprises of patients who are positive and responds positively to eradication therapy, group 2 comprises of patients who are positive and responds negatively to eradication therapy and group 3 is the control group and comprises of patients that are negative. Urine samples to obtain the protein/creatinine ratio were collected initially and at the end of the study from all patients. Mean difference levels (pre- and post-treatment difference) of urine protein/creatinine ratio was 0.055 +/- 0.13 in group 1. The ratio was -aEuro parts per thousand 0.0007 +/- 0.0067 in group 2 and -aEuro parts per thousand 0.0022 +/- 0.008 in group 3. A statistically significant difference was found in group 1 compared to the other groups in terms of mean difference levels of protein/creatinine ratios (p < 0.001). As a result of our study, treatment of eradication significantly reduced the proteinuria within the normal limits.en_US
dc.identifier.doi10.1007/s00508-012-0150-0
dc.identifier.endpage244en_US
dc.identifier.issn0043-5325
dc.identifier.issn1613-7671
dc.identifier.issue7-8en_US
dc.identifier.pmid22527813
dc.identifier.scopus2-s2.0-84863722888
dc.identifier.scopusqualityQ1
dc.identifier.startpage241en_US
dc.identifier.urihttps://doi.org/10.1007/s00508-012-0150-0
dc.identifier.urihttps://hdl.handle.net/11468/14489
dc.identifier.volume124en_US
dc.identifier.wosWOS:000304120000003
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringer Wienen_US
dc.relation.ispartofWiener Klinische Wochenschrift
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInfectionsen_US
dc.subjectHelicobacter Pylorien_US
dc.subjectImmune Responseen_US
dc.subjectTreatmenten_US
dc.subjectProteinuriaen_US
dc.titleEffects of eradication on proteinuria: a prospective studyen_US
dc.titleEffects of eradication on proteinuria: a prospective study
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu